Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTCH1 | P46531 | 5/20 | 0.80 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.75 |
| ▸ | CDK2 | P24941 | 1/20 | 0.75 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.75 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.75 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.75 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.75 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.75 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.75 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.75 |
| ▸ | KDM4E | B2RXH2 | 12/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.67 |
| ▸ | TSHR | P16473 | 4/20 | 0.67 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.67 |
| ▸ | TP53 | P04637 | 1/20 | 0.66 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | CASP1 | P29466 | 3/20 | 0.55 |
| ▸ | GLA | P06280 | 3/20 | 0.55 |
| ▸ | CASP7 | P55210 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16854567 | 0.90 | NOTCH1 (0.81) | NOTCH1CCNA2CDK2PSEN1PSEN2 | |
| SCHEMBL16854538 | 0.90 | NOTCH1 (0.81) | NOTCH1CCNA2CDK2PSEN1PSEN2 | |
| SCHEMBL15538182 | 0.89 | NOTCH1 (0.79) | NOTCH1CCNA2CDK2PSEN1PSEN2 | |
| SCHEMBL16854539 | 0.88 | NOTCH1 (0.79) | NOTCH1CCNA2CDK2PSEN1PSEN2 | |
| SCHEMBL3325137 | 0.87 | NOTCH1 (0.76) | NOTCH1CCNA2CDK2PSEN1PSEN2 | |
| SCHEMBL16850575 | 0.87 | NOTCH1 (0.75) | NOTCH1CCNA2CDK2PSEN1PSEN2 | |
| SCHEMBL16854540 | 0.87 | NOTCH1 (0.75) | NOTCH1CCNA2CDK2PSEN1PSEN2 | |
| SCHEMBL19366382 | 0.87 | NOTCH1 (0.75) | NOTCH1CCNA2CDK2PSEN1PSEN2 | |
| SCHEMBL15537010 | 0.87 | NOTCH1 (0.75) | NOTCH1CCNA2CDK2PSEN1PSEN2 | |
| SCHEMBL3326628 | 0.87 | NOTCH1 (0.75) | NOTCH1CCNA2CDK2PSEN1PSEN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2854809-B1 | INHIBITORS OF THE NOTCH SIGNALLING PATHWAY AND SECRETION FOR USE IN MEDICINE | LEIBNIZ-INSTITUT FÜR ALTERNSFORSCHUNG - FRITZ-LIPMANN-INSTITUT E V (FLI) (DE) | 2017-12-06 | — | — | EP | disclosed |
| EP-2854809-B1 | INHIBITORS OF THE NOTCH SIGNALLING PATHWAY AND SECRETION FOR USE IN MEDICINE | LEIBNIZ-INSTITUT FÜR ALTERNSFORSCHUNG - FRITZ-LIPMANN-INSTITUT E V (FLI) (DE) | 2017-12-06 | — | — | EP | disclosed |
| US-9828344-B2 | Inhibitors of the notch signaling pathway and secretion for use in medicine | LEIBNIZ-INSTITUT FÜR ALTERSFORSCHUNG FRITZ-LIPMANN-INSTITUT e.V. (FLI) (DE) | 2017-11-28 | — | — | US | disclosed |
| US-9828344-B2 | Inhibitors of the notch signaling pathway and secretion for use in medicine | LEIBNIZ-INSTITUT FÜR ALTERSFORSCHUNG FRITZ-LIPMANN-INSTITUT e.V. (FLI) (DE) | 2017-11-28 | — | — | US | disclosed |
| US-9828344-B2 | Inhibitors of the notch signaling pathway and secretion for use in medicine | LEIBNIZ-INSTITUT FÜR ALTERSFORSCHUNG FRITZ-LIPMANN-INSTITUT e.V. (FLI) (DE) | 2017-11-28 | — | — | US | disclosed |
| US-20150175548-A1 | INHIBITORS OF THE NOTCH SIGNALLING PATHWAY AND SECRETION FOR USE IN MEDICINE | LEIBNIZ-INSTITUT FÜR ALTERSFORSCHUNG FRITZ-LIPMANN-INSTITUT e.V. (FLI) (DE) | 2015-06-25 | — | — | US | disclosed |
| US-20150175548-A1 | INHIBITORS OF THE NOTCH SIGNALLING PATHWAY AND SECRETION FOR USE IN MEDICINE | LEIBNIZ-INSTITUT FÜR ALTERSFORSCHUNG FRITZ-LIPMANN-INSTITUT e.V. (FLI) (DE) | 2015-06-25 | — | — | US | disclosed |
| US-20150175548-A1 | INHIBITORS OF THE NOTCH SIGNALLING PATHWAY AND SECRETION FOR USE IN MEDICINE | LEIBNIZ-INSTITUT FÜR ALTERSFORSCHUNG FRITZ-LIPMANN-INSTITUT e.V. (FLI) (DE) | 2015-06-25 | — | — | US | disclosed |
| EP-2854809-A1 | INHIBITORS OF THE NOTCH SIGNALLING PATHWAY AND SECRETION FOR USE IN MEDICINE | Leibniz-Institut für Altersforschung - Fritz-Lipmann-Institut e.V. (DE) | 2015-04-08 | — | — | EP | disclosed |
| WO-2013178821-A1 | INHIBITORS OF THE NOTCH SIGNALLING PATHWAY AND SECRETION FOR USE IN MEDICINE | Leibniz-Institut für Altersforschung - Fritz-Lipmann-Institut e.V. (FLI) (DE) | 2013-12-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150175548-A1 | INHIBITORS OF THE NOTCH SIGNALLING PATHWAY AND SECRETION FOR USE IN MEDICINE | NOTCH1, HES1, NOTCH2 | NOTCH1 1/4885CCNA2 3104/4885CDK2 981/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.